VITASPRING BIOMEDICAL CO., LTD. Net Income (Loss) Allocated to Limited Partners
VITASPRING BIOMEDICAL CO., LTD. (VSBC) reported Net Income (Loss) Allocated to Limited Partners of $0 for the 12-month period ending 2021-01-31, per its 10-K filed 2021-04-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:NetIncomeLossAllocatedToLimitedPartners · last filed 2021-04-14
- VITASPRING BIOMEDICAL CO., LTD. net income (loss) allocated to limited partners for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- VITASPRING BIOMEDICAL CO., LTD. net income (loss) allocated to limited partners for fiscal 2020 was $6.92K.
- VITASPRING BIOMEDICAL CO., LTD. net income (loss) allocated to limited partners for fiscal 2019 was -$22.40K.
| Period end | Net Income (Loss) Allocated to Limited Partners 12 month |
|---|---|
| 2021-01-31 | $0.00 10-K · filed 2021-04-14 |
| 2020-01-31 | $6.92K 10-K · filed 2020-06-09 |
| 2019-01-31 | -$22.40K 10-K · filed 2020-06-09 |